Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Navis

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Seminars in Nephrology|December 26, 2001
Role of genetic variability in the renin-angiotensin system in diabetic and nondiabetic renal diseaseA Boonstra, D de Zeeuw, P E de Jong, et al.
Minerva Medica|October 7, 2004
Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?L Vogt, M J A Kocks, G D Laverman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 1999
Prevention of renal function loss after non-renal solid organ transplantation--how can nephrologists help to keep the kidneys out of the line of fire?J Broekroelofs, C A Stegeman, G Navis, et al.
Kidney International. Supplement|January 4, 1998
Renal hemodynamic effects of candesartan in normal and impaired renal function in humansH Buter, G Navis, D de Zeeuw, et al.
Drug Safety|September 1, 1996
ACE inhibitors and the kidney. A risk-benefit assessmentG Navis, H J Faber, D de Zeeuw, et al.
Clinical Pharmacology and Therapeutics|June 14, 2017
Biomarkers of Renal Function: Towards Clinical ActionabilityS Heleen Binnenmars, R S Hijmans, G Navis, et al.
Hypertension (Dallas, Tex. : 1979)|February 1, 1996
Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?P van Paassen, D de Zeeuw, G Navis, et al.
Kidney International|November 9, 2006
The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young menJ A Krikken, A T Lely, S J L Bakker, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2000
Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal functionP van Paassen, D de Zeeuw, G Navis, et al.
Experimental Nephrology|January 1, 1996
Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal diseaseF H Wapstra, G Navis, P E de Jong, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Seminars in Nephrology|December 26, 2001
Role of genetic variability in the renin-angiotensin system in diabetic and nondiabetic renal diseaseA Boonstra, D de Zeeuw, P E de Jong, et al.
Minerva Medica|October 7, 2004
Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?L Vogt, M J A Kocks, G D Laverman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 1999
Prevention of renal function loss after non-renal solid organ transplantation--how can nephrologists help to keep the kidneys out of the line of fire?J Broekroelofs, C A Stegeman, G Navis, et al.
Kidney International. Supplement|January 4, 1998
Renal hemodynamic effects of candesartan in normal and impaired renal function in humansH Buter, G Navis, D de Zeeuw, et al.
Drug Safety|September 1, 1996
ACE inhibitors and the kidney. A risk-benefit assessmentG Navis, H J Faber, D de Zeeuw, et al.
Clinical Pharmacology and Therapeutics|June 14, 2017
Biomarkers of Renal Function: Towards Clinical ActionabilityS Heleen Binnenmars, R S Hijmans, G Navis, et al.
Hypertension (Dallas, Tex. : 1979)|February 1, 1996
Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?P van Paassen, D de Zeeuw, G Navis, et al.
Kidney International|November 9, 2006
The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young menJ A Krikken, A T Lely, S J L Bakker, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2000
Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal functionP van Paassen, D de Zeeuw, G Navis, et al.
Experimental Nephrology|January 1, 1996
Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal diseaseF H Wapstra, G Navis, P E de Jong, et al.
Pageof 7